“Severe Hypoalbuminemia Increases the Risk of Thrombocytopenia in Critically Ill Adult Patients Receiving Teicoplanin”. Dhaka University Journal of Pharmaceutical Sciences, vol. 18, no. 2, Sept. 2019, pp. 153-7, https://doi.org/10.3329/dujps.v18i2.43257.